Literature DB >> 8931038

Hip fractures in France: the magnitude and perspective of the problem.

C Baudoin1, P Fardellone, B Thelot, R Juvin, V Potard, K Bean, J L Sebert.   

Abstract

Entities:  

Mesh:

Year:  1996        PMID: 8931038     DOI: 10.1007/bf01623756

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


× No keyword cloud information.
  39 in total

1.  Quality of death certificates: studying or burying?

Authors:  L R Salmi; F Dabis; C Rogier; T McKinley
Journal:  Am J Public Health       Date:  1990-06       Impact factor: 9.308

2.  Methodology of MEDOS multicentre study of hip fracture incidence: validity and relevance considerations.

Authors:  L Elffors; B Gullberg; E Allander; O Johnell; J A Kanis
Journal:  Bone       Date:  1993       Impact factor: 4.398

3.  The Mediterranean Osteoporosis Study (MEDOS): theoretical and practical issues of a major international project on hip fracture epidemiology.

Authors:  E Allander; B I Lindahl
Journal:  Bone       Date:  1993       Impact factor: 4.398

4.  The Mediterranean Osteoporosis (MEDOS) Study questionnaire.

Authors:  J Dequeker; J Ranstam; J Valsson; B Sigurgevisson; E Allander
Journal:  Clin Rheumatol       Date:  1991-03       Impact factor: 2.980

5.  [Femoral neck fractures after age 65: morbidity, mortality, lethality].

Authors:  L Tiret; F Hatton
Journal:  Rev Epidemiol Sante Publique       Date:  1987       Impact factor: 1.019

Review 6.  Significance of osteoporosis: a growing international health care problem.

Authors:  L V Avioli
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

7.  Cost analysis of osteoporosis related to untreated menopause.

Authors:  E Levy
Journal:  Clin Rheumatol       Date:  1989-06       Impact factor: 2.980

8.  Fracture of neck of the femur: changing incidence.

Authors:  A F Lewis
Journal:  Br Med J (Clin Res Ed)       Date:  1981-11-07

9.  The apparent incidence of hip fracture in Europe: a study of national register sources.

Authors:  O Johnell; B Gullberg; E Allander; J A Kanis
Journal:  Osteoporos Int       Date:  1992-11       Impact factor: 4.507

10.  Rising incidence of fracture of the proximal femur.

Authors:  W J Boyce; M P Vessey
Journal:  Lancet       Date:  1985-01-19       Impact factor: 79.321

View more
  7 in total

1.  Economic cost of the treatment of fractures among old people: a preliminary study in dakar teaching hospital.

Authors:  Charles Bertin Diémé
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-09

2.  Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database.

Authors:  Milka Maravic; Christine Le Bihan; Paul Landais; Patrice Fardellone
Journal:  Osteoporos Int       Date:  2005-10-11       Impact factor: 4.507

Review 3.  Hip fracture prevention: cost-effective strategies.

Authors:  P Vestergaard; L Rejnmark; L Mosekilde
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Change in hip fracture incidence over the last 6 years in France.

Authors:  M Maravic; P Taupin; P Landais; C Roux
Journal:  Osteoporos Int       Date:  2010-06-02       Impact factor: 4.507

5.  FRAX® probabilities and risk of major osteoporotic fracture in France.

Authors:  C M Couris; R D Chapurlat; J A Kanis; H Johansson; N Burlet; P D Delmas; A M Schott
Journal:  Osteoporos Int       Date:  2011-12-17       Impact factor: 4.507

6.  Characterisation of patients with postmenopausal osteoporosis in French primary healthcare.

Authors:  Francis Blotman; Bernard Cortet; Pascal Hilliquin; Bernard Avouac; François-André Allaert; Denis Pouchain; Anne-Françoise Gaudin; François-Emery Cotté; Abdelkader El Hasnaoui
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

7.  Geographical variations in hip fracture risk for women: strong effects hidden in standardised ratios.

Authors:  S Barbier; R Ecochard; A-M Schott; C Colin; P D Delmas; S B Jaglal; C M Couris
Journal:  Osteoporos Int       Date:  2008-07-18       Impact factor: 4.507

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.